bromodeoxyuridine has been researched along with Ovarian Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (34.38) | 18.7374 |
| 1990's | 11 (34.38) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DP; Chin-Sinex, H; Mendonca, MS; Nie, B; Wang, M | 1 |
| Anttonen, M; Bützow, R; Färkkilä, A; Heikinheimo, M; Kauppinen, M; Maclaughlin, DT; Tauriala, H; Unkila-Kallio, L | 1 |
| Balakrishnan, A; Chaillet, JR | 1 |
| Choi, KC; Hwang, KA; Jeung, EB; Lee, HR; Park, MA; Yi, BR | 1 |
| Aoki, D; Katsuki, Y; Komiyama, S; Nozawa, S | 1 |
| Gray, JW; Guan, Y; Neve, RM; Stilwell, JL | 1 |
| Avner, P; Fellous, M; Giovanella, BC; Nørgaard, JO; Rosén, A; Vaheri, A; Wartiovaara, J; Zeuthen, J | 1 |
| D'Incalci, M; Erba, E; Mascellani, E; Pifferi, A | 1 |
| Bolis, P; Danova, M; Erba, E; Giordano, M; Landoni, F; Mangioni, C; Mazzini, G; Tenti, P; Torri, V; Ubezio, P | 1 |
| Perras, JP; Ramos, R; Sevin, BU | 1 |
| Capizzi, RL; Fernandes, DJ; Wheeler, KT; Yang, JL | 1 |
| Danova, M; Dionigi, P; Ferrari, C; Giordano, M; Mazzini, G; Riccardi, A | 1 |
| Ng, CE; Raaphorst, GP; Wilkins, DE | 1 |
| Bergamaschi, D; Cappella, P; Erba, E; Faretta, M; Mascellani, E; Pantarotto, M; Ronzoni, S; Taverna, S; Ubezio, P | 1 |
| Bassano, L; D'Incalci, M; Erba, E; Giavazzi, R; Ronzoni, S | 1 |
| Gersell, DJ; Meyer, JS; Yim, S | 1 |
| Kao, GD; McKenna, WG; Yen, TJ | 1 |
| Carreiras, F; Cruet-Hennequart, S; Gauduchon, P; Luis, J; Maubant, S; Poulain, L; Sichel, F; Staedel, C | 1 |
| Bertuzzi, A; Faretta, M; Gandolfi, A; Sinisgalli, C; Starace, G; Ubezio, P; Valoti, G | 1 |
| Mathews, CK | 1 |
| Huang, HX | 1 |
| Cornelisse, CJ; Keijzer, R; van de Velde, CJ; van Dierendonck, JH; Wijsman, JH | 1 |
| Einhorn, N; Sahni, K; Tribukait, B | 2 |
| deFazio, A; Roberts, CG; Tattersall, MH | 1 |
| Hatano, M; Kamiya, S; Nakamura, S; Ogura, H; Ogura, T; Sato, H; Tanaka, J | 1 |
| Fojo, A; Hamilton, TC; Lai, GM; Masuda, H; Ozols, RF; Rothenberg, M | 1 |
| Izutsu, T; Kagabu, T; Kaneko, S; Matsuda, M; Nishiya, I; Yoshizaki, A | 1 |
| Fukuda, K; Hachisuga, T; Hayashi, Y; Iwasaka, T; Sugimori, H | 1 |
| Kärcher, H; Kärcher, KH; McNally, NJ; Pfragner, R; Wilson, G | 1 |
| Bektemirov, TA; Bykovsky, AF; Ilyin, KV; Irlin, IS; Mazurenko, NP; Soloviev, VD; Yershov, FI; Zhdanov, VM | 1 |
| Clark, J; Colby, C; Leffert, H; Morgan, M; Paul, D; Posner, M; Sato, G | 1 |
32 other study(ies) available for bromodeoxyuridine and Ovarian Neoplasms
| Article | Year |
|---|---|
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer.
Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Cisplatin; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ovarian Neoplasms; Superoxide Dismutase; Superoxide Dismutase-1; Trientine; Tumor Stem Cell Assay | 2009 |
Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Topics: Analysis of Variance; Animals; Anti-Mullerian Hormone; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; DNA Primers; Female; Granulosa Cell Tumor; Humans; Immunohistochemistry; Mice; Ovarian Neoplasms; Receptors, Peptide; Receptors, Transforming Growth Factor beta; Signal Transduction; Tetrazolium Salts; Thiazoles | 2011 |
Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas.
Topics: Animals; Bromodeoxyuridine; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Genotype; Granulosa Cells; Immunoblotting; Immunohistochemistry; In Situ Hybridization; Mice; Ovarian Follicle; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction; Statistics, Nonparametric; Teratoma; Transgenes | 2013 |
Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
Topics: Animals; Antimetabolites; Benzophenones; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Coloring Agents; Cyclin D1; Estrogen Receptor alpha; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; p21-Activated Kinases; Pregnancy; Real-Time Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Stimulation, Chemical; Xenograft Model Antitumor Assays | 2013 |
Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis.
Topics: Adenocarcinoma, Clear Cell; Animals; Bromodeoxyuridine; Cell Proliferation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-6; Mice; Mice, SCID; Neoplasm Staging; Ovarian Neoplasms; Proliferating Cell Nuclear Antigen; Transforming Growth Factor beta1; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2006 |
Systems biology in cancer research: genomics to cellomics.
Topics: Benzimidazoles; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; Genomics; Humans; Image Processing, Computer-Assisted; Ovarian Neoplasms; RNA, Small Interfering; Staining and Labeling; Statistics as Topic; Systems Biology; Tissue Array Analysis | 2007 |
Characterization of a human ovarian teratocarcinoma-derived cell line.
Topics: Antigens, Surface; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; Cells, Cultured; Embryonic Induction; Female; Genetic Markers; Hot Temperature; Humans; Karyotyping; Ovarian Neoplasms; Phenotype; Teratoma | 1980 |
Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
Topics: Alkylating Agents; Bromodeoxyuridine; Cell Cycle; Distamycins; DNA; DNA, Neoplasm; Female; Flow Cytometry; Humans; In Vitro Techniques; Melphalan; Nitrogen Mustard Compounds; Nucleic Acid Conformation; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
Topics: Analysis of Variance; Aneuploidy; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Feasibility Studies; Female; Flow Cytometry; Humans; Multivariate Analysis; Ovarian Neoplasms; Ploidies; Predictive Value of Tests; Prognosis; Regression Analysis; Sensitivity and Specificity | 1994 |
Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
Topics: Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA Replication; DNA, Neoplasm; Drug Synergism; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Pentoxifylline; S Phase; Tumor Cells, Cultured | 1993 |
PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartic Acid; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Nucleotides; Ovarian Neoplasms; Phosphonoacetic Acid; Time Factors; Tumor Stem Cell Assay | 1996 |
Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Feasibility Studies; Female; Flow Cytometry; Gastrointestinal Neoplasms; Glioma; Head and Neck Neoplasms; Humans; Neoplasms; Ovarian Neoplasms; Ploidies; Uterine Neoplasms | 1996 |
Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation.
Topics: Bromodeoxyuridine; Cell Cycle; Cisplatin; Combined Modality Therapy; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Radiotherapy Dosage; Tumor Cells, Cultured | 1997 |
Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis.
Topics: Bromodeoxyuridine; Cyclin B; Cyclin B1; DNA, Neoplasm; Female; Flow Cytometry; G2 Phase; Humans; Mitosis; Ovarian Neoplasms; Software; Tumor Cells, Cultured | 1998 |
The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Female; Humans; Metalloendopeptidases; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1999 |
Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Ploidies; Prognosis; S Phase; Survival Rate; Thymidine; Tritium | 2001 |
Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells.
Topics: Bromodeoxyuridine; Cell Cycle; Centromere; Chromosomal Proteins, Non-Histone; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Female; Flow Cytometry; G2 Phase; Gamma Rays; HeLa Cells; Humans; Kinetics; Microfilament Proteins; Ovarian Neoplasms; Radiation Tolerance; Tumor Cells, Cultured | 2001 |
Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antineoplastic Agents; Bromodeoxyuridine; Cell Adhesion; Cell Division; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Integrins; Ovarian Neoplasms; Receptors, Vitronectin; Tumor Cells, Cultured | 2002 |
Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
Topics: Animals; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Kinetics; Mice; Mice, Nude; Models, Biological; Ovarian Neoplasms; Tumor Cells, Cultured | 2002 |
Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Culture Media; Cytarabine; Deoxyuridine; DNA; Female; Floxuridine; Hormones; Hydroxyurea; Idoxuridine; Kinetics; Ovarian Neoplasms; Rats; Thymidine | 1975 |
[Agyrophilic nucleolar organizer region counts as related to bromodeoxyuridine incorporation scores in ovarian clear cell carcinoma cells].
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Female; Humans; Nucleolus Organizer Region; Ovarian Neoplasms; Silver; Staining and Labeling; Tumor Cells, Cultured | 1992 |
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Female; Flow Cytometry; G1 Phase; Humans; Immunohistochemistry; Methotrexate; Nuclear Proteins; Ovarian Neoplasms; Proliferating Cell Nuclear Antigen; Resting Phase, Cell Cycle; S Phase; Tamoxifen | 1991 |
Development of ploidy and cell proliferation in serial samples of ascites from patients with ovarian carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Ascites; Bromodeoxyuridine; Cell Division; Endometriosis; Female; Flow Cytometry; Follow-Up Studies; Humans; Interphase; Middle Aged; Ovarian Neoplasms; Ploidies | 1990 |
A simple and rapid method for the identification of cycling cells in freshly excised tumours.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cells, Cultured; Culture Media; DNA; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Ovarian Neoplasms; Staining and Labeling; Time Factors | 1985 |
Comparative study of proportion of S-phase cells in ascites and pleural effusions in ovarian carcinoma using antibromodeoxyuridine monoclonal antibody and DNA flow-cytometry.
Topics: Antibodies, Monoclonal; Ascites; Bromodeoxyuridine; DNA, Neoplasm; Female; Flow Cytometry; Humans; Interphase; Ovarian Neoplasms; Pleural Effusion | 1989 |
Latent infection of human ovarian teratocarcinoma cells with human cytomegalovirus. Brief report.
Topics: Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Cytomegalovirus; Female; Humans; Ovarian Neoplasms; Teratoma; Tretinoin; Virus Replication | 1986 |
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
Topics: Aphidicolin; Bromodeoxyuridine; Cell Line; Cisplatin; Diterpenes; DNA Repair; Drug Resistance; Female; Humans; Ovarian Neoplasms; Thymidine | 1988 |
Appreciation for malignancy on ovarian neoplasm by monoclonal antibody of BrdUrd.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Bromodeoxyuridine; Cystadenocarcinoma; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Teratoma | 1988 |
Immunocytochemical detection of S-phase cells in gynecologic malignancies using anti-BrdU monoclonal antibody.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cystadenocarcinoma; Female; Genital Neoplasms, Female; Humans; Immunohistochemistry; Interphase; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1988 |
[In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Interphase; Male; Ovarian Neoplasms; Sarcoma | 1987 |
Isolation of oncornaviruses from continuous human cell cultures.
Topics: Amnion; Astrocytoma; Bromodeoxyuridine; Carcinoma; Cell Line; Centrifugation, Density Gradient; Dactinomycin; Female; HeLa Cells; Humans; Kidney; Laryngeal Neoplasms; Microscopy, Electron; Mitomycins; Mycoplasma; Oncogenic Viruses; Ovarian Neoplasms; Retroviridae; RNA Viruses; RNA-Directed DNA Polymerase; RNA, Viral; Sarcoma; Stomach Neoplasms; Tritium; Uridine | 1973 |
Enrichment culture techniques for selection of cell culture strains with desirable physiological and genetic properties.
Topics: Animals; Bromodeoxyuridine; Carbon Isotopes; Culture Techniques; Female; Growth Hormone; Haploidy; Hepatectomy; Hybridization, Genetic; Hypophysectomy; Insulin; Interferons; Kidney Neoplasms; Leiomyosarcoma; Liver Regeneration; Male; Mammary Neoplasms, Experimental; Methods; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Prolactin; Rats; Selection, Genetic; Testicular Neoplasms; Thymidine; Thyrotropin; Thyroxine; Tritium; Vesicular stomatitis Indiana virus | 1971 |